Corteriapharma
Founded 2021 · 27 employees on LinkedIn · 8 known investors
Find your way into Corteriapharma
182 people in our graph share verified history with the Corteriapharma team — schools, employers, funds. One of them is your warm intro.
Michèle Ollierunlockedknows Marie-Laure Ozoux · together at Université Paris Cité (overlapped)
knows the team · via Corteriapharma
×3knows the team · via Pierre and Marie Curie University
×7knows the team · via Université Paris Cité
Corteria Pharma develops interceptive therapies aimed at treating subpopulations of patients with heart failure, sarcopenia, and obesity. The company operates in the biotech and drug development sector.
Founders & leadership
Corteriapharma was founded in 2021 by Philip Janiak, Marie-Laure Ozoux, and Régis Olivier.
PJ
Philip JaniakinFounder
MO
Marie-Laure OzouxinMarie-Laure Ozoux has consulted in healthcare across preclinical and clinical drug development programs spanning oncology, immunology, and cardiovascular diseases, with expertise in translational medicine, biomarkers, and biotherapeutics development.
RO
Régis OlivierinFounder
FC
Francesca C. Lawson
MK
Mark Kowala
EJ
Eleonore JouannyinFounder
SD
Stéphane Durant des AulnoisinFounder
Investors · 8
Fountain Healthcare Partners✓ verifiedDublin · $10.8M – $16.2M
Jeito Capital✓ verifiedParis
Kurma Partners✓ verifiedParis · $162K – $10.8M
OrbiMed✓ verifiedNew York · $1M – $75M
V-Bio Ventures✓ verifiedGhent · $270K – $2.2M
Omnes Capital✓ verifiedParis
Invivo Capital PartnersBarcelona · $2.2M – $4.3M
LifeArc VenturesLondon
Frequently asked questions
- What does Corteriapharma do?
- Corteria Pharma develops interceptive therapies aimed at treating subpopulations of patients with heart failure, sarcopenia, and obesity. The company operates in the biotech and drug development sector.
- Who founded Corteriapharma?
- Corteriapharma was founded by Philip Janiak, Marie-Laure Ozoux, Régis Olivier in 2021.
- Who are Corteriapharma's investors?
- Corteriapharma's investors include Fountain Healthcare Partners, Jeito Capital, Kurma Partners, OrbiMed, V-Bio Ventures, Omnes Capital, Invivo Capital Partners, LifeArc Ventures.